BioSpace News Archive

Rave Mobile Safety (Rave), a trusted partner for safety software protecting millions of individuals, today announced important upgrades to its Smart911 technology, adding new fields to Smart911 Safety Profiles to better serve homeless, and transient populations and individuals with mental health and cognitive conditions.

Sunrise Senior Living reports that Arena’s artificial intelligence solution has increased employee retention at its 265 U.S. senior living communities and lowered the cost of recruiting new staff and hiring temporary workers.

Perfuze, a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke, has closed a €3 million seed investment round.

Results from this research could ultimately lead to the acceleration of clinical genomic analysis and precision medicine diagnoses at scale.

SCIEX, a global leader in life science analytical technologies, today announced that the San Francisco Office of the Chief Medical Examiner (SFOCME) is transforming the City and County’s forensic testing with the addition of eight cutting-edge SCIEX systems to its analytical capabilities.

New Jersey’s poorest zip codes have the highest incidence of people with chronic conditions seeking care in hospital emergency rooms, revealing barriers to the ongoing supportive care that individuals need to manage their chronic illness.

This in vivo study, evaluated the efficacy of varying compositions of active ingredients in cannabis to induce sleep, in comparison to Diazepam, the active ingredient in Valium.

According to Coherent Market Insights, the global drug eluting balloon market was valued at US$ 420.0 Million in 2017, and is projected to exhibit a CAGR of 8.1 % over the forecast period (2018 – 2026).

DUROLANE is a single-injection, hyaluronic acid product used for joint lubrication in the treatment of pain associated with knee osteoarthritis.

The global intrauterine contraceptive devices (IUD) market research report by Technavio predicts the market to post a CAGR of close to 4% during the period 2019-2023.